Artiva Biotherapeutics, Inc. Common Stock (ARTV) — Defensive Interval Ratio
Artiva Biotherapeutics, Inc. Common Stock (ARTV) has a Defensive Interval Ratio of 3228 days as of September 2025. Defensive assets of $98.34 Million (cash $-, short-term investments $97.46 Million, receivables $879.00K) cover 3228 days of daily cash needs of $30.46K/day.
Defensive Interval Ratio
Defensive Assets
Daily Cash Need
Current Liabilities
Artiva Biotherapeutics, Inc. Common Stock Defensive Interval Ratio (2020–2024)
This chart shows how Artiva Biotherapeutics, Inc. Common Stock's Defensive Interval Ratio has evolved across 5 annual periods from 2020 to 2024. As of September 2025, the ratio stands at 3228 days, meaning defensive assets of $98.34 Million can fund 3228 days of operations without new revenue. For the complete balance sheet picture, see ARTV current and non-current assets.
Annual Defensive Interval Ratio for Artiva Biotherapeutics, Inc. Common Stock (2020–2024)
The table below presents the year-by-year Defensive Interval Ratio for Artiva Biotherapeutics, Inc. Common Stock from 2020 to 2024, covering 5 annual filings. Each row shows defensive assets, daily cash need, the DIR in days, and the change in days compared to the prior year. See Artiva Biotherapeutics, Inc. Common Stoc (ARTV) working capital ratio to evaluate short-term liquidity relative to the company's equity base.
| Year | DIR (days) | Defensive Assets (USD) | Daily Cash Need | Cash | ST Investments | Change (days) |
|---|---|---|---|---|---|---|
| 2024 | 4329 days | $145.34 Million | $33.57K/day | $- | $145.19 Million | ▲ +3576 days |
| 2023 | 753 days | $25.23 Million | $33.50K/day | $- | $23.47 Million | ▲ +746 days |
| 2022 | 7 days | $525.00K | $70.21K/day | $- | $0.00 | ▼ -1 days |
| 2021 | 9 days | $468.00K | $52.89K/day | $- | $- | ▲ +9 days |
| 2020 | 0 days | $0.00 | $15.79K/day | $- | $- | — |